Epimune's dedicated team combines scientific rigor with diagnostic industry expertise!
Uwe Staub, PhD
Chief Executive Officer (CEO)
Uwe was appointed as CEO of Epimune on April 01st, 2019. Prior to joining Epimune, Uwe was part of Epigenomics' executive team, and before that, held management positions at Qiagen, Digene and Abbott.
Christoph Sachsenmaier, PhD
Vice President Business Development
Christoph is responsible for Epimune's business development activities. Before joining Epimune, he served as a business development executive at ApoCell, Beckman Coulter Genomics, Epigenomics and ProQinase.
Epimune is supported by experts from the life science and healthcare industry, high-profile academic researchers and senior advisors with extensive experience in clinical practise, regulatory affairs and finance.